Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Mauricio, Sarmiento"'
Autor:
Francisco Barriga, Ute V. Solloch, Anette Giani, Julia Palma, Angélica Wietstruck, Mauricio Sarmiento, Cristian Carvallo, Claudio Mosso, Pablo Ramirez, Matias Sanchez, Nicolas Rojas, Jorge Alfaro, Sebastian Saldaña, Karen Ende, Denis Flaig, Ignacia Pattillo, Alexander H. Schmidt
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed worldwide to treat blood cancer and other life-threatening blood disorders. As successful transplantation requires an HLA-compatible donor, unrelated donor center
Externí odkaz:
https://doaj.org/article/3c4a83bac11e489cb3b06931bfc79074
Autor:
Funes, David Romero, Montorfano, Lisandro, Blanco, David Gutierrez, Cobos, Mauricio Sarmiento, Lo Menzo, Emanuele, Szomstein, Samuel, Agrawal, Neerja, Rosenthal, Raul J.
Publikováno v:
In Surgery for Obesity and Related Diseases June 2022 18(6):772-778
Autor:
Martín Dib, Nicole Le Corre, Catalina Ortiz, Daniel García, Marcela Ferrés, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, María José Ojeda, Manuel A. Espinoza, Aquiles Jara, Juan Pablo Arab, Ricardo Rabagliati, Cecilia Vizcaya, María Elena Ceballos, Mauricio Sarmiento, Sebastián Mondaca, Macarena Viñuela, Antonia Pastore, Vania Szwarcfiter, Elizabeth Galdames, Aldo Barrera, Pablo Castro, Nicolás MS Gálvez, Jorge A. Soto, Susan M. Bueno, Alexis M. Kalergis, Bruno Nervi, M. Elvira Balcells
Publikováno v:
The Lancet Regional Health. Americas, Vol 16, Iss , Pp 100371- (2022)
Summary: Background: Solid-organ transplant (SOT) recipients have worse COVID-19 outcomes than general population and effective immunisation in these patients is essential but more difficult to reach. We aimed to determine the immunogenicity of an mR
Externí odkaz:
https://doaj.org/article/c59988b4c6e44e479dc4cb836721da24
Autor:
Mauricio Sarmiento, Veronica Jara, Katherine Soto, Pablo Uribe, Mauricio Ocqueteau, Pablo Bertin, Jaime Pereira
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 3, Pp 303-308 (2021)
Introduction: Graft-versus-host disease (GVHD) is a serious complication in allogeneic transplantation. The first-line treatment is high doses of corticosteroids. In the absence of response to corticosteroids, several immunosuppressive drugs can be u
Externí odkaz:
https://doaj.org/article/2cded7ee6d6446beb0b41ac1e4b72cdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mauricio Sarmiento, Pablo Ramirez, Veronica Jara, Pablo Bertin, Mauricio Galleguillos, Isabel Rodriguez, Carla Lorca, Isabel Pizarro, Elizabeth Rivera, Mauricio Ocqueteau
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 1, Pp 40-45 (2020)
Introduction: Patients with benign or malignant blood disorders, who require allogeneic stem cell transplantation and lack an identical human leukocyte antigen HLA identicalHL sibling donor, could be transplanted with hematopoietic stem cells from un
Externí odkaz:
https://doaj.org/article/103f0c268ee549909b64b6b1494c014b
Autor:
Roberto J. Valera, Cristina Botero-Fonnegra, Vicente J. Cogollo, Mauricio Sarmiento-Cobos, Lisandro Montorfano, Carlos Rivera, Liang Hong, Emanuele Lo Menzo, Samuel Szomstein, Raul J. Rosenthal
Publikováno v:
Surgery for Obesity and Related Diseases. 19:548-554
Stroke is the second leading cause of death worldwide and fifth in the United States, and it represents the major cause of disability in older adults.We aimed to determine the risk of acute ischemic stroke (AIS) in individuals with obesity with a his
Publikováno v:
ARS Medica, Vol 46, Iss 2 (2021)
Introducción: las histiocitosis son un grupo heterogéneo de enfermedades; una de ellas es el síndrome hematofagocítico (SHF). Sus causas pueden ser infecciosas, neoplásicas, autoinmunes o relacionadas a inmunodeficiencias adquiridas; el linfoma
Externí odkaz:
https://doaj.org/article/aef04cbec42f43848d91993bba7238db
Autor:
María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, Ricardo Castro, Mauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, Patricio Ross, Jaime Santander, Bárbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, Carlos Balmaceda, Manuel A Espinoza, Jaime Pereira, Bruno Nervi
Publikováno v:
PLoS Medicine, Vol 18, Iss 3, p e1003415 (2021)
BackgroundConvalescent plasma (CP), despite limited evidence on its efficacy, is being widely used as a compassionate therapy for hospitalized patients with COVID-19. We aimed to evaluate the efficacy and safety of early CP therapy in COVID-19 progre
Externí odkaz:
https://doaj.org/article/cad36da3c89d489a88e5f731d6d4f0ea
Autor:
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón
Publikováno v:
Experimental Hematology & Oncology, Vol 6, Iss 1, Pp 1-9 (2017)
Abstract Background Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed the role of activation of JAK pathways in alloreactive lymphocytes. Some
Externí odkaz:
https://doaj.org/article/7840b2d58f9743b79988cbc36a8f2f07